Cargando…
Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX
Pharmaceutical companies developed Covid-19 vaccines in record time. However, it soon became apparent that global access to the vaccines was inequitable. Through a qualitative inquiry as the pandemic unfolded (to mid-2021), we provide an in-depth analysis of why companies engaged with the Covid-19 V...
Autores principales: | Scholz, Markus, Smith, N. Craig, Riegler, Maria, Burton, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102828/ http://dx.doi.org/10.1177/00076503231158600 |
Ejemplares similares
-
Strengthening or Restricting? Explaining the Covid-19 Pandemic’s Configurational Effects on Companies’ Sustainability Strategies and Practices
por: Hamann, Ralph, et al.
Publicado: (2022) -
International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility
por: ECCLESTON‐TURNER, MARK, et al.
Publicado: (2021) -
An anatomy of carewashing: Corporate branding and the commodification
of care during Covid-19
por: Chatzidakis, Andreas, et al.
Publicado: (2022) -
The house cannot be full: Risk, anxiety, and the politics of
collective spectatorship in a pandemic
por: Chatterjee, Tupur
Publicado: (2022) -
COVAX – Time to reconsider the strategy and its target
por: Bell, David, et al.
Publicado: (2023)